Keep pulling the thread on Bessent Visits Japan.
Japanese authorities are attempting to prevent the yen from weakening past the 160 yen per U.S. dollar level.
A rate hike from the Bank of Japan is widely expected at its June meeting.
There is a growing consensus among Federal Reserve policymakers who may be inclined to raise interest rates as their next policy move.
The year-over-year Consumer Price Index (CPI) for April is expected to be 3.7%, an increase from the previous month's 3.3%.
The core Consumer Price Index (CPI) is expected to increase to 2.7% from the previous month's 2.6%.
The Personal Consumption Expenditures (PCE) price index, which the Federal Reserve monitors, was 3.2% year-over-year as of a few weeks ago.
The core Producer Price Index (PPI) is expected to rise to 4.3% in April from 3.8% in March.
The total Producer Price Index (PPI), including food and energy, is expected to show a 5% increase in April.
The retail sales control group number is expected to decline to 0.4% from 0.7% in the upcoming April report.
Hims & Hers Health has a partnership with Novo Nordisk to sell the weight-loss drug Wegovy on its platform.
JP Morgan initiated coverage on Hims & Hers Health with an overweight rating, citing the company's deal with Novo Nordisk.
Options markets are pricing in a potential 13% move in the share price of Hims & Hers Health following its upcoming earnings report.